|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.52 | 88.89 | 103.80 | 0.54 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Hospital & Healthcare Services
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
395.90
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | -65.44 | -19.50 | -10.81 | -25.98 | -3.03 | CEPS(Rs) | -42.61 | 7.19 | 13.86 | 8.08 | 8.66 | DPS(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Book NAV/Share(Rs) | 9.98 | 67.99 | 78.04 | 86.11 | 122.95 | Tax Rate(%) | 0.00 | 0.00 | 0.00 | -163.64 | 58.38 | Margin Ratios | | | | | | Core EBITDA Margin(%) | -14.71 | 10.08 | 15.35 | 18.06 | 1.70 | EBIT Margin(%) | -29.27 | -8.34 | -1.50 | 0.47 | -3.24 | Pre Tax Margin(%) | -47.94 | -18.08 | -12.06 | -6.30 | -4.53 | PAT Margin (%) | -47.94 | -18.08 | -12.06 | -16.61 | -1.89 | Cash Profit Margin (%) | -31.22 | 6.66 | 15.47 | 5.17 | 5.39 | Performance Ratios | | | | | | ROA(%) | -27.33 | -8.49 | -4.83 | -12.38 | -1.64 | ROE(%) | -167.83 | -26.71 | -13.17 | -24.85 | -2.28 | ROCE(%) | -37.77 | -8.05 | -1.42 | 0.67 | -3.87 | Asset Turnover(x) | 0.57 | 0.47 | 0.40 | 0.75 | 0.87 | Sales/Fixed Asset(x) | 1.11 | 0.97 | 0.80 | 1.83 | 2.95 | Working Capital/Sales(x) | -2.92 | -4.63 | -3.37 | -6.48 | -12.10 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 0.90 | 1.03 | 1.26 | 0.55 | 0.34 | Receivable days | 10.30 | 12.49 | 17.13 | 10.67 | 8.40 | Inventory Days | 43.10 | 56.41 | 81.77 | 56.84 | 58.96 | Payable days | 356.87 | 605.09 | 556.25 | 481.75 | 697.57 | Valuation Parameters | | | | | | PER(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | PCE(x) | -5.94 | 48.76 | 21.37 | 13.78 | 82.61 | Price/Book(x) | 25.37 | 5.15 | 3.80 | 1.29 | 5.82 | Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | EV/Net Sales(x) | 2.28 | 3.75 | 3.47 | 0.75 | 4.43 | EV/Core EBITDA(x) | -18.19 | 22.88 | 13.32 | 3.37 | 109.69 | EV/EBIT(x) | -7.80 | -44.97 | -231.26 | 158.65 | -136.93 | EV/CE(x) | 1.34 | 1.64 | 1.46 | 0.50 | 3.86 | M Cap / Sales | 1.86 | 3.25 | 3.31 | 0.71 | 4.46 | Growth Ratio | | | | | | Net Sales Growth(%) | 26.55 | 20.36 | -42.71 | -2.61 | 4.28 | Core EBITDA Growth(%) | -196.80 | -24.17 | -32.97 | 436.16 | 451.31 | EBIT Growth(%) | -343.87 | -569.80 | -281.63 | 114.23 | 41.45 | PAT Growth(%) | -235.56 | -80.42 | 58.40 | -757.71 | 70.33 | EPS Growth(%) | -235.56 | -80.42 | 58.40 | -757.71 | 70.40 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 7.03 | 0.88 | 0.21 | 0.08 | 0.00 | Current Ratio(x) | 0.56 | 0.69 | 0.62 | 0.70 | 0.82 | Quick Ratio(x) | 0.41 | 0.48 | 0.38 | 0.42 | 0.47 | Interest Cover(x) | -1.57 | -0.86 | -0.14 | 0.07 | -2.50 | Total Debt/Mcap(x) | 0.28 | 0.17 | 0.06 | 0.06 | 0.00 |
|
|
|
|
|
|